# Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression

> **NCT06419608** · PHASE2 · COMPLETED · sponsor: **Biohaven Therapeutics Ltd.** · enrollment: 336 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** BHV-7000
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06419608
- **Lead sponsor:** Biohaven Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-05-28
- **Primary completion:** 2025-11-07
- **Final completion:** 2025-11-07
- **Target enrollment:** 336 (ACTUAL)
- **Last updated:** 2026-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06419608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06419608, "Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06419608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*